These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 166611)

  • 21. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters.
    Renis HE
    Antimicrob Agents Chemother; 1977 Apr; 11(4):701-7. PubMed ID: 856023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
    Fitzwilliam JF; Griffith JF
    J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed mice.
    Ijichi K; Ashida N; Machida H
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2431-3. PubMed ID: 1965108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
    Klein RJ; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO; Kennell WL; Poirier RH; Lynd FT
    Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of cutaneous herpesvirus infection of hairless mice.
    Lieberman M; Schafer TW; Came PE
    J Invest Dermatol; 1973 Apr; 60(4):203-6. PubMed ID: 4349225
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine.
    Colacino J; Brownridge E; Greenberg N; Lopez C
    Antimicrob Agents Chemother; 1986 May; 29(5):877-82. PubMed ID: 3015008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of herpes simplex virus clones and drug resistant mutants in microcultures.
    Klein RJ
    Arch Virol; 1975; 49(1):73-80. PubMed ID: 172951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
    Klein RJ; Friedman-Kien AE; Brady E
    Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
    Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
    Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
    Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aciclovir-resistant herpes simplex virus infection in an immuno-depressed patient. Favourable effect of foscarnet].
    Charmot G; Ingrand D; Simon F; Kernbaum S; Fegueux S; De Truchis P; Coulaud JP
    Presse Med; 1990 Dec; 19(41):1905-6. PubMed ID: 2148390
    [No Abstract]   [Full Text] [Related]  

  • 39. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice.
    Hill JM; Wiggins CA; Kwon BS; Gentry GA; Gangarosa LP
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):17-20. PubMed ID: 6717166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isolation and characteristics of a mutant herpes simplex virus type 1 resistant to phosphonoacetic acid].
    Gibadulin RA; Denisova TS; Zavgorodniĭ SG; Florent'ev VL; Zhdanov VM
    Vopr Virusol; 1983; 28(4):59-63. PubMed ID: 6314671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.